Gohealth, Inc. · NASDAQ:GOCO

Gohealth — Q4 2024 Earnings Presentation

12 slides from Gohealth's earnings presentation, Feb 27, 2025

  1. Slide 1: Fourth Quarter and Full Year 2024 Results

    Fourth Quarter and Full Year 2024 Results February 27, 2025

  2. Slide 2: Forward-Looking Statements

    FORWARD-LOOKING STATEMENTS This earnings presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking

  3. Slide 3: Use of Non-GAAP Financial Measures and Key Performance Indicators

    USE OF NON-GAAP FINANCIAL MEASURES AND KEY PERFORMANCE INDICATORS Non-GAAP Financial Measures In this earnings presentation we use supplemental measures of our performance that are derived from our consolidated financial information, but which are not presented in our Condensed Consolidated Financia

  4. Slide 4: Q4'24 Financial Comparison Year-over-Year

    Q4’24 Financial Comparison Year-over-Year Revenue and Adjusted EBITDA improvements Q4’23 TO Q4’24 Q4’23 TO Q4’24 REVENUE ADJ. EBITDA2 $M1 $M1 41% 107% $389.1 $117.8 $276.7 $57.0 Q4'23 Q4'24 Q4'23 Q4'24 1. There may be slight differences compared to numbers shown in the Press Release due to rounding.

  5. Slide 5: FY'24 Financial Comparison Year-over-Year

    FY’24 Financial Comparison Year-over-Year Revenue and Adjusted EBITDA improvements FY’23 TO FY’24 FY’23 TO FY’24 REVENUE ADJ. EBITDA2 $M1 $M1 9% 60% $798.9 $120.3 $734.7 $75.1 FY'23 FY'24 FY'23 FY'24 1. There may be slight differences compared to numbers shown in the Press Release due to rounding. 2

  6. Slide 6: Commissions Receivable and Cash Flow from Operations Year-over-Year

    Commissions Receivable and Cash Flow from Operations Year-over-Year Shift in enrollments from Non-Agency to Agency contracts, a dynamic expected to remain fluid year-to-year, was influenced by various market factors and dynamics. Investment of capital during the fourth quarter in both e-TeleQuote an

  7. Slide 7: Q4'24 Medicare Unit Economics Year-over-Year

    Q4’24 Medicare Unit Economics Year-over-Year Continued improvements in efficiency and cost-effectiveness drive lower Direct Operating Cost per Submission SALES PER SUBMISSION2 DIRECT OPERATING COST PER SUBMISSION3 16% UNIT ECONOMICS PER SUBMISSION ($’s in ones)1 27% Q4’23 $957 Q4’24 $804 $688 $501 Q

  8. Slide 8: FY'24 Medicare Unit Economics Year-over-Year

    FY’24 Medicare Unit Economics Year-over-Year Continued improvements in efficiency and cost-effectiveness drive lower Direct Operating Cost per Submission SALES PER SUBMISSION2 DIRECT OPERATING COST PER SUBMISSION3 10% UNIT ECONOMICS PER SUBMISSION ($’s in ones)1 15% FY’23 $866 FY’24 $781 $683 $578 F

  9. Slide 9: Appendix

    Appendix GoHealtht 9

  10. Slide 10: Appendix – Reconciliation of Net Income to Adjusted EBITDA

    Appendix – Reconciliation of Net Income to Adjusted EBITDA The following table sets forth the reconciliations of GAAP net income (loss) to EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin for the periods presented: Three months ended Dec. 31, (in thousands)1 2024 2023 1. Numbers may not sum due to

  11. Slide 11: Appendix – Reconciliation of Net Income to Adjusted EBITDA

    Appendix – Reconciliation of Net Income to Adjusted EBITDA The following table sets forth the reconciliations of GAAP net income (loss) to EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin for the periods presented: Twelve months ended Dec. 31, (in thousands)1 2024 2023 Net revenues $798,894 $734,6

  12. Slide 12: GoHealth.com

    GoHealth.com | 222 W. Merchandise Mart Plaza, Suite 1750, Chicago, IL 60654 | 1-312-386-8200 Copyright © 2025 GoHealth. All Rights Reserved. 12

GoHealth — Q4 2024 Earnings Presentation on 6ix